Medicina
Fachbereich
Hospital Clínico de la Universidad de Chile
Santiago de Chile, ChilePublikationen in Zusammenarbeit mit Forschern von Hospital Clínico de la Universidad de Chile (21)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)
World Allergy Organization Journal, Vol. 16, Núm. 3
2022
-
Nutritional care is a human right: Translating principles to clinical practice
Clinical Nutrition, Vol. 41, Núm. 7, pp. 1613-1618
-
Nutritional care is a human right: Translating principles to clinical practice
Nutrition in Clinical Practice, Vol. 37, Núm. 4, pp. 743-751
2021
-
Clinical Nutrition and Human Rights. An International Position Paper
Nutrition in Clinical Practice, Vol. 36, Núm. 3, pp. 534-544
-
Clinical nutrition and human rights. An international position paper
Clinical Nutrition, Vol. 40, Núm. 6, pp. 4029-4036
-
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
Journal of Hepatology, Vol. 75, Núm. 5, pp. 1026-1033
-
Infective Endocarditis in Patients on Chronic Hemodialysis
Journal of the American College of Cardiology, Vol. 77, Núm. 13, pp. 1629-1640
2019
-
Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)
British Journal of Cancer, Vol. 121, Núm. 7, pp. 537-544
-
Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 6, pp. 373-379
-
Sepsis in the emergency department: Key points, controversies, and proposals for improvements in Latin America
Emergencias, Vol. 31, Núm. 2, pp. 123-135
2017
-
Dual Therapy with Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy with Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Clinical Infectious Diseases, Vol. 65, Núm. 12, pp. 2112-2118
2015
-
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis
Circulation, Vol. 131, Núm. 2, pp. 131-140
-
Candida infective endocarditis: An observational cohort study with a focus on therapy
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 4, pp. 2365-2373
-
Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study
Clinical Infectious Diseases, Vol. 60, Núm. 5, pp. 741-749
-
One-year outcome following biological or mechanical valve replacement for infective endocarditis
International Journal of Cardiology, Vol. 178, pp. 117-123
2013
-
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
PLoS ONE, Vol. 8, Núm. 5
-
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke
Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 209-217
2011
-
Revisión de las novedades presentadas en el XXVI Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (I)
Revista de Neurologia, Vol. 52, Núm. 4, pp. 227-238